BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//California Life Sciences - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:California Life Sciences
X-ORIGINAL-URL:https://www.califesciences.org
X-WR-CALDESC:Events for California Life Sciences
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260430T160000
DTEND;TZID=America/Los_Angeles:20260430T180000
DTSTAMP:20260603T223454
CREATED:20260427T202211Z
LAST-MODIFIED:20260427T202211Z
UID:10001073-1777564800-1777572000@www.califesciences.org
SUMMARY:BioBeats
DESCRIPTION:Science first.  Social next.\nMove from Lab to Lounge over delicious appetizers\, beer and wine at the next installment of the BioBeats Series\, which brings the life science community together over live music and relaxed conversations.  See the latest products from leading suppliers\, and network with colleagues.  No cost to attend this community event.\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/bioev-biobeats/
LOCATION:Timber & Tide\, 685 Gateway Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260430T084500
DTEND;TZID=America/Los_Angeles:20260430T173000
DTSTAMP:20260603T223454
CREATED:20260401T221727Z
LAST-MODIFIED:20260401T221727Z
UID:10001051-1777538700-1777570200@www.califesciences.org
SUMMARY:Vendor Scientific Highlights Symposium: DMPK & Bioanalytical Technologies and Case Studies
DESCRIPTION:This symposium will highlight emerging strategies and practical considerations in drug metabolism\, bioanalysis\, and translational sciences for novel therapeutic modalities. As the industry moves beyond traditional small molecules toward increasingly complex platforms — including oligonucleotides\, peptides\, and antibody–drug conjugates (ADCs) — there is a growing need for fit-for-purpose ADME characterization and advanced analytical approaches. \nExpert speakers from industry will share real-world case studies and methodological advances addressing in vitro ADME characterization and innovative LC–MS bioanalytical strategies across a range of therapeutic modalities. Topics will include modality-specific challenges\, comparison of novel modalities with small molecules\, and lessons learned from both cleavable and non-cleavable ADC linker systems. \nThis event will provide valuable insights for scientists working in DMPK\, bioanalysis\, and translational research\, offering practical perspectives on how evolving analytical technologies are being applied to support drug discovery and development in a rapidly changing therapeutic landscape. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/vendor-scientific-highlights-symposium/
LOCATION:Crowne Plaza Hotel\, Foster City\, 1221 Chess Dr\, Foster City\, CA\, 94404\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T160000
DTEND;TZID=America/Los_Angeles:20260429T190000
DTSTAMP:20260603T223454
CREATED:20260427T161055Z
LAST-MODIFIED:20260427T161055Z
UID:10001072-1777478400-1777489200@www.califesciences.org
SUMMARY:Strategic R&D Partner Seminar
DESCRIPTION:PROGRAM HIGHLIGHTS\n\n4:00 PM Registration & Welcome\n4:20 PM Talk session\n\nAutomated Platform for Pharmaceutical Formulation Development\n\nKenan Pandza\, VP of R&D — Persist AI\n\n\nOne Vision\, Two Strategies: Integrated & Open-Platform Lab Automation\n\nAndy Sasaki\, GM R&D Center — Shimadzu Scientific Instruments\n\n\nFind the Needle in the Haystack with FAST Fluorescence Imaging\n\nJoerg Martini\, Assoc. Director — SRI International\n\n\nAI-Driven Culture Media Optimization for Biopharmaceuticals\n\nHirotaka Kuroda\, Senior Researcher — Shimadzu Corporation\n\n\n\n\n6:00 PM Networking & Poster Session\n\nPAT\, NAMs\, Particle Separation & more\n\n\n\nKEY TOPICS\nLab Automation • HPLC & LCMS & Analytics • Cell Culture AI • Fluorescence Imaging • Drug Formulation • PAT • Particle Separation • NAMs • Centrifugal Field-flow Fractionation • Pharma R&D \nIdeal for pharmaceutical scientists\, analytical chemists\, bioprocess engineers\, and life science researchers \nREGISTER»
URL:https://www.califesciences.org/event/strategic-rd-partner-seminar/
LOCATION:The Forum\, 750 Gateway Blvd\, South San Francisco\, 94080\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T070000
DTEND;TZID=America/Los_Angeles:20260429T093000
DTSTAMP:20260603T223454
CREATED:20260409T224039Z
LAST-MODIFIED:20260409T224039Z
UID:10001062-1777446000-1777455000@www.califesciences.org
SUMMARY:Obtaining Executive Roles
DESCRIPTION:Brought by: Hands On Learning (handscom.com) a specialist in leadership development and coaching for Life Sciences. \nJoin us in this interactive panel discussion with Q&A on practical tips\, guidance\, and candid lessons learned from Life Sciences and Technology executives. What you’ll learn / gain: \n– What it takes to obtain an executive-level role\n– Practical tips and guidance on how to get there\n– Gain direct exposure to industry executives\n– Grow your professional network \n$195.00 per person. Typically reimbursable by your organization. Contact info@handscom.com to learn more. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/obtaining-executive-roles/
LOCATION:https://www.califesciences.org/event/obtaining-executive-roles/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T070000
DTEND;TZID=America/Los_Angeles:20260429T080000
DTSTAMP:20260603T223454
CREATED:20260312T164850Z
LAST-MODIFIED:20260312T164850Z
UID:10001040-1777446000-1777449600@www.califesciences.org
SUMMARY:Rapid and flexible analytical characterization of oligonucleotides
DESCRIPTION:Therapeutic oligonucleotides (ASOs\, siRNA and conjugates) present analytical challenges due to their structural diversity and chemical modifications. In early discovery\, robust UV×MS purity assessment and impurity profiling are essential for both crude oligonucleotide libraries prior to early screening and purified batches prior to advanced assays. \nHere\, we present a streamlined LC–UV–MS platform comprising two methods paired with (semi-)automated data processing to increase analytical throughput and accelerate decision-making. First\, a flexible characterization method provides chromatographic separation and UV×MS purity/impurity analysis for purified ASOs\, siRNA and conjugates\, with semi-automated processing and automated reporting enabled by the Byos Oligo App. Second\, a high-throughput method delivers online desalting\, rapid MS fingerprinting\, purity analysis and impurity-class profiling for crude ASO and siRNA single‑strand libraries at scale (hundreds per day). \nTogether\, these methods provide a fast\, scalable and fit‑for‑purpose framework for oligonucleotide characterization in early drug discovery. \nKey takeaways:\n\nFit‑for‑purpose LC–UV–MS workflows We developed two analytical methods\, one for detailed characterization of purified batches and one for high‑throughput screening of crude libraries\, covering early discovery needs.\n(Semi-)automated data analysis We integrated data analysis tools\, such as the Byos Oligo workflow\, to enable semi‑automated UV×MS purity determination and impurity assignment with automated reporting\, reducing manual effort and variability.\nStandardized reporting We implemented standardized outputs to deliver consistent purity/impurity metrics for oligonucleotides\, improving comparability across libraries and individual samples.\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/rapid-and-flexible-analytical-characterization-of-oligonucleotides-2026/
LOCATION:https://www.califesciences.org/event/rapid-and-flexible-analytical-characterization-of-oligonucleotides-2026/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260429
DTEND;VALUE=DATE:20260501
DTSTAMP:20260603T223454
CREATED:20260213T182236Z
LAST-MODIFIED:20260213T182236Z
UID:10001009-1777420800-1777593599@www.califesciences.org
SUMMARY:Pharma Partnering US Summit 2026
DESCRIPTION:The Pharma Partnering Summit is an exclusive Life Sciences Industry event\, with the aim to help companies expand their network and put together licensing deals\, research collaborations and financing. Our platform brings together senior executives from different parts of the world specialising in Business Development & Licensing\, Alliance Management\, Research Collaborations\, M&A and Investment. In addition to identifying products and partners as well as investors\, the forum also serves to disseminate knowledge through expert speakers\, for the best practices in the field of industry partnerships. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/pharma-partnering-us-summit-2026/
LOCATION:Hilton Garden Inn – San Diego/Del Mar\, 3939 Ocean Bluff Ave\, San Diego\, CA\, 92130\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260428T100000
DTEND;TZID=America/Los_Angeles:20260428T113000
DTSTAMP:20260603T223454
CREATED:20260312T163254Z
LAST-MODIFIED:20260312T163254Z
UID:10001037-1777370400-1777375800@www.califesciences.org
SUMMARY:Navigating Leadership in Biopharma
DESCRIPTION:HAVEN and Hands-On Learning have joined forces to create a powerful development journey designed to accelerate impact for biotech employees who have project management or people management responsibilities or ambitions. This curated experience blends human-centered leadership development with technical skills—building confidence\, competence\, and connection fast. \nREGISTER»
URL:https://www.califesciences.org/event/navigating-leadership-in-biopharma/
LOCATION:https://www.califesciences.org/event/navigating-leadership-in-biopharma/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260427
DTEND;VALUE=DATE:20260429
DTSTAMP:20260603T223454
CREATED:20260213T190018Z
LAST-MODIFIED:20260213T190018Z
UID:10001016-1777248000-1777420799@www.califesciences.org
SUMMARY:Stanford Drug Discovery Symposium
DESCRIPTION:Welcome to the 10th annual Stanford Drug Discovery Symposium\, which will be held at the Arrillaga Alumni Center on the Stanford University campus. This milestone year marks a decade of bringing together all members of the drug discovery community\, including researchers\, pharmaceutical companies\, investment groups\, and the broader biomedical community. Over two days\, attendees will experience a dynamic program with cutting-edge talks\, robust panel discussions\, an outstanding poster session showcasing innovative research\, and a platform for networking. We look forward to welcoming you to the 10th annual SDDS\, and to meaningful conversations and new collaborations that emerge from this year’s event. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/stanford-drug-discovery-symposium-2026/
LOCATION:Frances C. Arrillaga Alumni Center\, 326 Galvez St\, Stanford\, CA\, 94305\, United States
CATEGORIES:Industry Collaboration & Networking,Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260424T140000
DTEND;TZID=America/Los_Angeles:20260424T180000
DTSTAMP:20260603T223454
CREATED:20260327T184014Z
LAST-MODIFIED:20260327T184014Z
UID:10001047-1777039200-1777053600@www.califesciences.org
SUMMARY:o2h ChaiTime - Discovery Club | featuring Cambridge Chemistry Club
DESCRIPTION:We are excited to introduce o2h ChaiTime — Discovery Club – an invite-only forum designed to bring together Medicinal Chemists and Drug Discovery leaders for an open\, peer-led discussion on emerging therapeutic areas and modalities. \n​Agenda\n​14:00 – 14:30 — Arrival & Networking\n14:30 – 14:35 — Welcome & Introduction\n14:35 – 15:10 — Scientific Talk – Sarah Skerratt\, PhD\, Chief Research Officer\, Isomorphic Labs\n15:10 – 15:45 — Scientific Talk – David Barrett\, Head of Engineered Small Molecules & Oncology Research\, Astellas Pharma\n15:45 – 16:00 — Short Break\n16:00 – 16:35 — Scientific Talk – Nigel Ramsden\, PhD\, VP\, Drug Discovery\, Cerevance\n16:35 – 17:10 — Scientific Talk – Hitesh Sanganee\, Venture Partner\, Octopus Ventures\n17:10 – 17:15 — Closing Comments\n17:15 – 18:00 — Drinks & Networking \nFeaturing the Cambridge Chemistry Club\, we are bringing together a curated group of biotech leaders and decision-makers to present and discuss emerging modalities\, evolving drug discovery strategies\, and real-world insights across diverse therapeutic areas. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/o2h-chaitime-discovery-club/
LOCATION:https://www.califesciences.org/event/o2h-chaitime-discovery-club/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260424T120000
DTEND;TZID=America/Los_Angeles:20260424T130000
DTSTAMP:20260603T223454
CREATED:20260413T211932Z
LAST-MODIFIED:20260413T211932Z
UID:10001063-1777032000-1777035600@www.califesciences.org
SUMMARY:Bolstering the Workforce Pipeline: Early Career Awareness in the Life Sciences
DESCRIPTION:The Life Sciences Workforce Collaborative (LSWC) is hosting its second Best Workforce Strategies Roundtable on April 24\, convening industry association and workforce leaders focused on early career awareness in the life sciences. \nThe session will feature Ying-Tsu Loh\, Executive Director of BABEC\, who will discuss how the organization equips high school teachers to bring biotechnology into classrooms; Angie McMurry\, Director of Industry Engagement at Ohio Life Sciences\, presenting BioPathways\, a comprehensive education initiative that brings industry and academia together to help teachers inspire and prepare K-12 students for rewarding careers in life sciences; Shelly Ridder\, Community Engagement Manager at Oregon Life Sciences\, highlighting career exploration tools from STEM Engineering\, Radlabs and Biotech-Careers.org; and Ann Vogel\, SVP of Charitable Programs at iBIO Institute\, presenting STEMgirls Camp—a 5-day STEM summer program for 3rd–8th grade girls. \nAs the U.S. life sciences sector grows\, most students have little or no exposure to biotechnology until college. This Roundtable will spotlight scalable solutions to close that gap and ensure a skilled\, future-ready workforce. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/early-career-awareness-in-the-life-sciences/
LOCATION:https://www.califesciences.org/event/early-career-awareness-in-the-life-sciences/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260423T160000
DTEND;TZID=America/Los_Angeles:20260423T190000
DTSTAMP:20260603T223454
CREATED:20260303T205310Z
LAST-MODIFIED:20260303T205310Z
UID:10001033-1776960000-1776970800@www.califesciences.org
SUMMARY:Capital Connect: From Seed to Series A in Today’s Market
DESCRIPTION:Join Foley\, CollectiveMinds\, HSBC Innovation Banking\, and Magnet in Silicon Valley for Capital Connect\, a high‑value look at what early‑stage life science companies need to move from Seed to Series A in an increasingly diligence‑driven market. \nHear insights from venture investors\, repeat founder‑CEOs\, seasoned biotech operators\, and senior intellectual property legal experts. They’ll dive into investor expectations\, smart milestone design\, intellectual property and legal essentials\, early team building\, operational readiness\, and real‑world lessons from recent fundraises. This discussion will offer practical guidance and meaningful connections for Seed and early Series A founders\, CEOs\, investors\, and advisors navigating an increasingly rigorous market. \nREGISTER» \nHosted by: \n \n 
URL:https://www.califesciences.org/event/capital-connect-from-seed-to-series-a-in-todays-market/
LOCATION:525 University Ave\, 525 University Ave\, Palo Alto\, CA\, 94301\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260422T170000
DTEND;TZID=America/Los_Angeles:20260422T190000
DTSTAMP:20260603T223454
CREATED:20251110T192432Z
LAST-MODIFIED:20260316T190711Z
UID:10000937-1776877200-1776884400@www.califesciences.org
SUMMARY:SoCal Social: Sustainability in Life Sciences
DESCRIPTION:Celebrate Earth Day by joining fellow life sciences professionals for CLS’s newest event\, SoCal Social\, a networking reception dedicated to sustainability in the life sciences. Attendees will enjoy:  \nNetworking Reception: Build connections with like-minded peers and sustainability champions in the life sciences community over light refreshments and food\, including local California beer and wine. \nVendor Showcase: Explore innovative solutions and products from industry-leading vendors to help reduce environmental impact in your operations. \nREGISTER» \n \nSPONSORSHIP OPPORTUNITIES\nCo-Host (Exclusive) – $10\,000\nNon-Member – $15\,000\n◆ Co-host logo recognition alongside California Life Sciences logo in official event branding\n◆ Opportunity to host a short panel discussion\, sharing your sustainability best practices\n◆ Table-top display + opportunity to distribute branded promotional materials and swag\n◆ Access to the final attendee list for pipeline development\n◆ Premier logo recognition on all event marketing and promotional materials \nExhibitor (Limited) – $2\,000\nNon-Member – $4\,000\n◆ Table-top display + opportunity to distribute branded promotional materials and swag\n◆ Access to the final attendee list for pipeline development\n◆ Logo recognition as a supporter on event website\, pre-event promotion including email and social channels\, onsite signage and digital program \nContact sponsorship@califesciences.org for more information about sponsorships.
URL:https://www.califesciences.org/event/socal-social-2026/
LOCATION:CA
CATEGORIES:California Life Sciences,Industry Collaboration & Networking
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/04.22-SoCal-Social.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260422
DTEND;VALUE=DATE:20260423
DTSTAMP:20260603T223454
CREATED:20260407T195747Z
LAST-MODIFIED:20260407T195747Z
UID:10001053-1776816000-1776902399@www.califesciences.org
SUMMARY:UNLOCK 2026 - AI Science: Cutting Through The Hype
DESCRIPTION:UNLOCK is a one day summit for where AI powered science is headed. Hear from people like David Baker\, Aviv Regev\, SVPs at big pharma\, CEOs/Founders at the cutting edge\, and more. \n\nLearn from the builders and operators doing this work today: Our speaker lineup includes researchers\, founders\, and industry leaders who are actively pushing the boundaries of AI in science grounded in real tangible work.\nConnect with the right people: The room will include pharma executives\, AI researchers\, investors\, founders\, and technical operators. The overlap of those groups in one place doesn’t happen often.\nGet ahead of the curve: People that are learning what others at the forefront of science are doing have an advantage. UNLOCK is a chance to pressure-test your own thinking against the people doing the work.\n\n\nCLS members receive a 50% discount to attend the summit. Contact your account manager or reach out to bd@califesciences.org for more information. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/unlock-2026/
LOCATION:City View at Metreon\, 135 4th St\, San Francisco\, CA\, 94103\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260417T084500
DTEND;TZID=America/Los_Angeles:20260417T173000
DTSTAMP:20260603T223454
CREATED:20260401T221451Z
LAST-MODIFIED:20260401T221451Z
UID:10001050-1776415500-1776447000@www.califesciences.org
SUMMARY:Small Molecule Preclinical Development and IND Filing: Nuts and Bolts
DESCRIPTION:Investigational new drug (IND) application is an important milestone that marks the entry of a molecule into clinical development. Knowing the objectives\, expectations\, and processes of assembling and filing an IND is the key to not only a successful filing but also a promising clinical development path forward. Often\, there are cases where too many nice-to-have studies crowd in the package but critical studies/issues are not addressed\, and this can lead to significant delays in clinical development. Additionally\, the regulatory environment is changing as rapidly as the industry. Therefore\, keeping up to date on the regulatory requirements and the industry’s best practices in different aspects including non-clinical safety\, PK\, CMC\, and clinical plan is paramount. In this workshop\, our speakers highly experienced with IND filings will discuss systemically the preclinical studies required for small molecule IND filings and the nuts\, bolts\, and best practices for putting together a high-quality IND package\, as well as how to interact with various regulatory agencies. \nTopics:\n\nOverview of preclinical development and IND filing for small molecules\nKey preclinical studies required (Safety\, DMPK & CMC)\nClinical Development plans\nRegulatory strategies\nInteracting with regulatory agencies\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/small-molecule-preclinical-development/
LOCATION:Hilton San Francisco Airport Bayfront\, 600 Airport Blvd\, Burlingame\, CA\, 94010\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260416T073000
DTEND;TZID=America/Los_Angeles:20260416T090000
DTSTAMP:20260603T223454
CREATED:20260312T162648Z
LAST-MODIFIED:20260313T154808Z
UID:10001036-1776324600-1776330000@www.califesciences.org
SUMMARY:AI in Life Sciences
DESCRIPTION:https://www.califesciences.org/wp-content/uploads/2026/03/Banner-1-ADVANCING-AI-IN-LIFE-SCIENCES.mp4\n  \nThis live 90 minute session will provide an overview of the latest trends and evolutions in AI in Life Sciences (covering BioPharma\, Med Tech and other sectors in Life Sciences)\, case studies on real applications and uses of AI in Life Sciences\, practical considerations on evolving AI in your business and more! This live session will be held on 16 April from 10:30am-12pm EST. \nREGISTER» \nHosted by: \n \n 
URL:https://www.califesciences.org/event/ai-in-life-sciences/
LOCATION:https://www.califesciences.org/event/ai-in-life-sciences/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260415T090000
DTEND;TZID=America/Los_Angeles:20260415T100000
DTSTAMP:20260603T223454
CREATED:20260213T183914Z
LAST-MODIFIED:20260213T183914Z
UID:10001012-1776243600-1776247200@www.califesciences.org
SUMMARY:Evaluation of Multi-Protein Quantitation Workflow for Host Cell Protein Analysis
DESCRIPTION:You never know what you’ll find when you look inside—and that’s exactly the challenge with host cell protein analysis. This webinar explores the evaluation of a multi-protein quantitation workflow for detecting and performing label-free quantitation of host cell proteins (HCPs). The workflow’s performance was compared to the established Host Cell Protein workflow\, showing comparable results after initial parameter optimization. Key insights into the workflow’s accuracy and quantitation capabilities will be shared\, emphasizing its potential as a robust alternative for HCP analysis in biopharmaceutical processes. \nKey Takeaways\n\nComparison of multi-protein quantitation workflow with the standard HCP workflow revealed comparable performance after parameter optimization\nThe workflow provides robust accuracy and quantitation capabilities for HCP detection\nThis approach offers a promising alternative for streamlining HCP analysis in early-phase biopharmaceutical development\nParameter adjustments are critical for achieving optimal results in label-free quantitation workflow\n\nOur Speaker\nJames York is a Principal Scientist at GlaxoSmithKline (GSK) with expertise in R&D and early-phase development. His day-to-day work includes supporting cell line selection\, characterization\, and molecule de-risking to advance biopharmaceutical innovation. James brings over 10 years of industrial experience in the development of novel biopharmaceuticals and characterization. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/evaluation-of-multi-protein-quantitation-workflow/
LOCATION:https://www.califesciences.org/event/evaluation-of-multi-protein-quantitation-workflow/
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260413
DTEND;VALUE=DATE:20260414
DTSTAMP:20260603T223454
CREATED:20260409T215842Z
LAST-MODIFIED:20260409T215842Z
UID:10001060-1776038400-1776124799@www.califesciences.org
SUMMARY:Structured Intelligence: How AI Is Transforming High-Stakes R&D Decisions
DESCRIPTION:Is your AI strategy ready for high-stakes R&D decisions? 🤖🔬 \nIn the complex world of drug discovery\, the difference between a breakthrough and a bottleneck often comes down to how we use data. But as the volume of research grows\, how do we move beyond the hype of AI to find actionable intelligence? \nJoin Digital Science for this on-demand webinar: “Structured Intelligence: How AI is transforming high-stakes R&D decisions.” \nHear from industry leaders across pharmaceutical\, chemical\, and technology sectors as they discuss:\n✅ Rethinking the role of AI in strategic decision-making.\n✅ Moving from fragmented data to connected insights.\n✅ Practical frameworks for navigating the evolving R&D landscape. \nPerfect for R&D leaders at CLS looking to set new benchmarks for performance. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/structured-intelligence/
LOCATION:https://www.califesciences.org/event/structured-intelligence/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260409T150000
DTEND;TZID=America/Los_Angeles:20260409T180000
DTSTAMP:20260603T223454
CREATED:20260330T230400Z
LAST-MODIFIED:20260330T230400Z
UID:10001049-1775746800-1775757600@www.califesciences.org
SUMMARY:The Forum Science & Tech Expo - High Throughput Automation Meets AI Self-Driving Lab
DESCRIPTION:There is no cost for attendees. From big data to fast action. Learn how the fusion of high-throughput automation and AI is transforming traditional labs into autonomous engines of innovation. \nEnjoy beer & wine and tasty appetizers while seeing the latest life science products and technologies from 40 suppliers. Keynote speaker will be Will Serber\, General Manager of Ginkgo Bioworks. Plus there will be very cool presentations from BD Biosciences and Automation Trainer. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/the-forum-science-tech-expo/
LOCATION:The Forum\, 750 Gateway Blvd\, South San Francisco\, 94080\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260409T130000
DTEND;TZID=America/Los_Angeles:20260409T170000
DTSTAMP:20260603T223454
CREATED:20260312T165205Z
LAST-MODIFIED:20260312T165205Z
UID:10001041-1775739600-1775754000@www.califesciences.org
SUMMARY:CGT Symposium: In Vivo CAR-T Innovation
DESCRIPTION:One‑day symposium to bring together leading experts to discuss the rapidly evolving landscape of in vivo CAR-T. \nIn vivo CAR-T has attracted significant attention from venture capital and the pharmaceutical industry. By offering the potential to overcome some of the most persistent constraints of ex vivo CAR-T\, including expensive and complex workflows and limited scalability\, this approach addresses challenges that often create financial barriers to patient access. At the same time\, new scientific and engineering solutions are needed to tackle issues such as achieving efficient and selective in vivo delivery\, controlling CAR expression\, and improving safety and efficacy in order to build a reliable therapeutic modality. \nThe Bay Area In Vivo CAR-T Symposium aims to bring together scientists to discuss the emerging challenges and innovations shaping this rapidly evolving field. Through short talks and discussions\, the event seeks to foster dialogue and collaboration across the growing ecosystem of researchers working to turn the promise of in vivo CAR-T into reality. \nThe symposium will be held at Timber & Tide from 1:00 to 5:00 PM\, followed by a networking happy hour from 5:00 to 6:00 PM. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/cgt-symposium-in-vivo-car-t-innovation/
LOCATION:Timber & Tide\, 685 Gateway Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260409T083000
DTEND;TZID=America/Los_Angeles:20260409T123000
DTSTAMP:20260603T223454
CREATED:20260226T211440Z
LAST-MODIFIED:20260327T191939Z
UID:10001023-1775723400-1775737800@www.califesciences.org
SUMMARY:Beyond the Tipping Point
DESCRIPTION:How Life Science Leaders Are Protecting Margin and Benefits in the Age of Healthcare Inflation and AI\nHosted by California Life Sciences and HUB International\, these exclusive forums bring together HR\, Finance\, and Executive leaders from life science companies for a data-driven conversation about two tipping points reshaping their businesses simultaneously\, the unsustainable trajectory of healthcare costs and the AI transformation reshaping every workplace. \nThis program is ideal for HR\, Finance\, and Executive leaders from life science companies with 200-3\,000 employees to gain the information and frameworks they need to lead boldly in a disrupted environment. \nHosted in two convenient locations\, this program is designed to foster connections\, spark conversation\, and explore pressing questions on AI adoption and healthcare purchasing \n\nApril 8\, 8:30-12:30PM | South San Francisco (Timber + Tide on Gateway Blvd) – Click here to RSVP\nApril 9\, 8:30AM-12:30PM | San Diego (The Boardwalk at Science Center Drive) – Click here to RSVP\n\nProgram\n8:30AM | Registration\, Breakfast\, Networking\n9:00AM-12:00PM | Programming\nMilliman – The Healthcare Cost Crisis: Why the Status Quo Is No Longer Viable \nHealthcare costs have reached a tipping point. For employers and plan sponsors\, the question is no longer whether to act — it’s whether you can afford not to. \nMilliman’s experts will make the case for why the status quo is broken and what high-performance companies are doing differently. Drawing on proprietary research and real-world data\, this session unpacks the forces driving today’s healthcare cost crisis — from the seismic impact of GLP-1 medications on pharmacy spend\, to mounting fiduciary obligations under ERISA\, to the hidden costs buried in PBM contracts that most employers never see coming. \nThe takeaway isn’t just a diagnosis — it’s a playbook. Attendees will leave with concrete strategies to close the transparency gap\, manage spiraling Rx costs\, and make smarter\, data-driven benefits decisions that protect both their people and their bottom line. \nThe status quo is no longer viable. This session will show you what’s next. \nHUB International & Pareto Health – The Path Forward: Self-Funded Captive Solutions for Life Science Companies \nThe deck is stacked. Fully-insured carriers have engineered their products to ensure one outcome — that they win. For California employers between 300 and 1\,500 employees\, that means absorbing unpredictable cost increases year after year while having little visibility into what’s actually driving them. \nBut there’s a growing divide between companies that have accepted this arrangement as inevitable and those that haven’t. High-performance employers in this size range are discovering that partially self-insuring — long considered the domain of large enterprises — is not only accessible\, it may be the most powerful lever available to control costs\, improve plan performance\, and deliver better outcomes for their employees. \nThis session is designed specifically for HR and Finance leaders who haven’t yet explored self-insurance — not to sell you on it\, but to equip you with the knowledge to evaluate whether it’s right for your company\, risk tolerance\, and your long-term total rewards objectives. \nBecause the first step to breaking the cycle isn’t a decision — it’s due diligence. \nMcKinsey & Company – Beyond the Tipping Point: AI\, Leadership\, and the Cost of Waiting \nThe McKinsey Global Institute brings its latest research on AI and the future of work to the Life Sciences & Pharma sector\, offering a data-driven look at what may be the most significant workforce transformation in a century. With 68% of jobs requiring fundamental reimagination by 2030 and AI fluency demand growing 4.7x faster than any other skill\, pharma and medical manufacturing organizations face urgent decisions about how to adapt. This presentation breaks down how work will be divided between people\, AI agents\, and robots; which roles and skills face the greatest disruption; and how leaders can navigate the shift through workflow redesign\, smart skilling\, and talent redeployment — with up to $31 billion in economic value potentially on the line for the sector in the US. \n12:00PM | Keynote Speaker & Lunch\n\nSan Diego Only | Fireside Chat with Rick Neale\, EVP and Chief Growth Officer of Scripps Health \nTo close the program\, we go inside the system itself. \nRick Neale\, EVP and Chief Growth Officer at Scripps Health\, brings a perspective that few executives are willing to offer publicly — an unfiltered look at the structural pressures bearing down on hospital and provider systems\, and what they mean for the employers and employees on the other side of the bill. \nAs the architect of Scripps’ strategic growth and the lead voice in the high-stakes Scripps/Anthem negotiations\, Rick sits at the exact intersection of cost\, access\, and institutional survival that defines today’s healthcare crisis. What’s driving costs isn’t abstract — its decisions being made right now\, in real time\, by health systems navigating their own unsustainable realities. \nThis is your opportunity to hear directly from the other side of the table — and to ask the questions that rarely get answered in a boardroom. \n\nThis event is closed to service provider attendees that are not current members of California Life Sciences. Contact BD@califesciences.org to learn more about becoming a member. \nREGISTER FOR THE SAN DIEGO EVENT» \nHosted in partnership with:
URL:https://www.califesciences.org/event/beyond-the-tipping-point-sd/
LOCATION:The Boardwalk at Science Center Drive\, 10275 Science Center Drive\, San Diego\, CA\, 92121\, United States
CATEGORIES:California Life Sciences,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260408T083000
DTEND;TZID=America/Los_Angeles:20260408T123000
DTSTAMP:20260603T223454
CREATED:20260226T211257Z
LAST-MODIFIED:20260327T191713Z
UID:10001022-1775637000-1775651400@www.califesciences.org
SUMMARY:Beyond the Tipping Point
DESCRIPTION:How Life Science Leaders Are Protecting Margin and Benefits in the Age of Healthcare Inflation and AI\nHosted by California Life Sciences and HUB International\, these exclusive forums bring together HR\, Finance\, and Executive leaders from life science companies for a data-driven conversation about two tipping points reshaping their businesses simultaneously\, the unsustainable trajectory of healthcare costs and the AI transformation reshaping every workplace. \nThis program is ideal for HR\, Finance\, and Executive leaders from life science companies with 200-3\,000 employees to gain the information and frameworks they need to lead boldly in a disrupted environment. \nHosted in two convenient locations\, this program is designed to foster connections\, spark conversation\, and explore pressing questions on AI adoption and healthcare purchasing \n\nApril 8\, 8:30-12:30PM | South San Francisco (Timber + Tide on Gateway Blvd) – Click here to RSVP\nApril 9\, 8:30AM-12:30PM | San Diego (The Boardwalk at Science Center Drive) – Click here to RSVP\n\nProgram\n8:30AM | Registration\, Breakfast\, Networking\n9:00AM-12:00PM | Programming\nMilliman – The Healthcare Cost Crisis: Why the Status Quo Is No Longer Viable \nHealthcare costs have reached a tipping point. For employers and plan sponsors\, the question is no longer whether to act — it’s whether you can afford not to. \nMilliman’s experts will make the case for why the status quo is broken and what high-performance companies are doing differently. Drawing on proprietary research and real-world data\, this session unpacks the forces driving today’s healthcare cost crisis — from the seismic impact of GLP-1 medications on pharmacy spend\, to mounting fiduciary obligations under ERISA\, to the hidden costs buried in PBM contracts that most employers never see coming. \nThe takeaway isn’t just a diagnosis — it’s a playbook. Attendees will leave with concrete strategies to close the transparency gap\, manage spiraling Rx costs\, and make smarter\, data-driven benefits decisions that protect both their people and their bottom line. \nThe status quo is no longer viable. This session will show you what’s next. \n  \nHUB International & Pareto Health – The Path Forward: Self-Funded Captive Solutions for Life Science Companies \nThe deck is stacked. Fully-insured carriers have engineered their products to ensure one outcome — that they win. For California employers between 300 and 1\,500 employees\, that means absorbing unpredictable cost increases year after year while having little visibility into what’s actually driving them. \nBut there’s a growing divide between companies that have accepted this arrangement as inevitable and those that haven’t. High-performance employers in this size range are discovering that partially self-insuring — long considered the domain of large enterprises — is not only accessible\, it may be the most powerful lever available to control costs\, improve plan performance\, and deliver better outcomes for their employees. \nThis session is designed specifically for HR and Finance leaders who haven’t yet explored self-insurance — not to sell you on it\, but to equip you with the knowledge to evaluate whether it’s right for your company\, risk tolerance\, and your long-term total rewards objectives. \nBecause the first step to breaking the cycle isn’t a decision — it’s due diligence. \n  \nMcKinsey & Company – Beyond the Tipping Point: AI\, Leadership\, and the Cost of Waiting \nThe McKinsey Global Institute brings its latest research on AI and the future of work to the Life Sciences & Pharma sector\, offering a data-driven look at what may be the most significant workforce transformation in a century. With 68% of jobs requiring fundamental reimagination by 2030 and AI fluency demand growing 4.7x faster than any other skill\, pharma and medical manufacturing organizations face urgent decisions about how to adapt. This presentation breaks down how work will be divided between people\, AI agents\, and robots; which roles and skills face the greatest disruption; and how leaders can navigate the shift through workflow redesign\, smart skilling\, and talent redeployment — with up to $31 billion in economic value potentially on the line for the sector in the US. \n\n12:00PM | Lunch & Networking\nThis event is closed to service provider attendees that are not current members of California Life Sciences. Contact BD@califesciences.org to learn more about becoming a member. \nREGISTER FOR THE SAN FRANCISCO EVENT» \nHosted in partnership with:
URL:https://www.califesciences.org/event/beyond-the-tipping-point-ssf/
LOCATION:Timber & Tide\, 685 Gateway Blvd\, South San Francisco\, CA\, 94080\, United States
CATEGORIES:California Life Sciences,Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260408T070000
DTEND;TZID=America/Los_Angeles:20260408T080000
DTSTAMP:20260603T223454
CREATED:20260312T164513Z
LAST-MODIFIED:20260312T164513Z
UID:10001039-1775631600-1775635200@www.califesciences.org
SUMMARY:How to Simplify ADC Characterization
DESCRIPTION:Characterizing a lysine-conjugated ADC with 3-4 drug molecules scattered across dozens of possible sites is a daunting analytical challenge — but with the right enzymatic strategy and analytical workflows\, it becomes straightforward. Arginine-specific digestion with GingisREX eliminates the missed cleavages that plague trypsin-based peptide mapping of conjugated lysines\, producing cleaner chromatograms and more reliable quantification. When paired with Byos intact reconstruction\, peptide-level and intact-level results can be directly compared — giving you orthogonal confirmation of drug loading in a single analysis. \nIn this webinar\, Genovis will introduce their GlyCLICK® platform for site-specific ADC generation and their enzymatic tools for ADC characterization\, followed by Protein Metrics demonstrating how Byos workflows — PTM analysis\, ADC intact DAR calculation\, and intact reconstruction — enable comprehensive characterization of lysine-conjugated ADCs. \nWhat You Will Learn\n\nHow site-specific conjugation with GlyCLICK simplifies ADC generation and analysis\nWhy arginine-specific digestion with GingisREX produces cleaner peptide maps for lysine-conjugated ADCs\nHow to use Byos PTM and ADC workflows for peptide-level and intact-level characterization\nHow intact reconstruction correlates peptide mapping data with intact mass data for orthogonal DAR confirmation\n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/how-to-simplify-adc-characterization/
LOCATION:https://www.califesciences.org/event/how-to-simplify-adc-characterization/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260408
DTEND;VALUE=DATE:20260409
DTSTAMP:20260603T223454
CREATED:20260211T201453Z
LAST-MODIFIED:20260211T201702Z
UID:10000979-1775606400-1775692799@www.califesciences.org
SUMMARY:From the Laboratory to Leadership - San Francisco
DESCRIPTION:It’s both an incredibly exciting and challenging time for the life science industry. Some companies are enjoying tailwinds as the result of great clinical data\, their proximity to product approval\, or they find themselves in a hot therapeutic space. Others\, may be more challenged\, as access to capital remains difficult\, putting their progress through the clinic in jeopardy\, or they may be trying to accelerate performance with fewer\, yet\, highly critical people. \nWhether you are scaling your organization for growth or right-sizing your company and upskilling your talent\, people are at the heart of everything you do. They are the innovators\, the motivators\, the problem solvers and your source of inspiration. At their best\, together\, they accelerate the pace at which you bring outstanding\, life-changing solutions to the patients who need them. \nHighly talented\, skilled and aligned leadership has never been more critical. We can help. \nOver 35 years of experience in organizational development is reflected in our From the Laboratory To Leadership program. By leveraging our extensive industry-specific knowledge combined with the most progressive and engaging professional development methods available\, we have successfully transformed over 7500 science-minded\, first-time managers\, into highly capable and confident business leaders. (do we want to say highly capable and confident leaders of people?). \nFrom the Laboratory to Leadership begins by helping participants assess who they are as leaders – their strengths\, styles\, and personal brand. From there\, we develop skills in the areas of communication\, priority management\, meeting management\, goal setting and planning\, delegation\, performance management\, and leading teams in a dynamic workplace. We wrap up the program in a fashion that brings all the learning together in a fun and impactful way. To drive high levels of engagement and impact\, this program integrates learning pods\, encourages participants to use their companies as learning labs\, and helps clients set goals that deliver measurable results. \n\nThis in-person workshop takes place in San Francisco on April 8\, April 22\, May 6\, and May 20 from 8:30 a.m. to 4:30 p.m. PT. \n\nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/from-the-laboratory-to-leadership-san-francisco/
LOCATION:The Forum\, 750 Gateway Blvd\, South San Francisco\, 94080\, United States
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260407T090000
DTEND;TZID=America/Los_Angeles:20260409T163000
DTSTAMP:20260603T223454
CREATED:20260217T165156Z
LAST-MODIFIED:20260217T165156Z
UID:10001018-1775552400-1775752200@www.califesciences.org
SUMMARY:3-Day Lyophilization Technology Training Course: Product\, Processes & Systems
DESCRIPTION:Biopharma Technology\, LLC\, is hosting a 3-day product\, process\, and systems workshop\, from April 7th to April 9th\,2026 at the modern Future Facility™ at Open Biopharma Research and Training Institute in Carlsbad. \nWith over 18 hours of lyophilization content\, this 3-day comprehensive lyo training course provides an opportunity to explore a wide range of elements across the lyophilization process. From characterization of products to cycle development and scale up\, we cover the science and engineering of lyophilization. \nDuring the course we will also discuss fundamental equipment features of refrigeration\, vacuum and control systems i.e. PAT tools\, and aspects of troubleshooting\, maintenance and qualification making it ideal for anyone in the pharmaceutical\, biotech\, or diagnostic sectors seeking to expand their knowledge of lyophilization. \nSecure your place today – Register Today (Pay by card or pro forma invoice) \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/lyophilization-technology-training-course/
LOCATION:Open Biopharma Research and Training Institute\, 1958 Kellogg Ave\, Carlsbad\, CA\, 92009\, United States
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260406T083000
DTEND;TZID=America/Los_Angeles:20260406T153000
DTSTAMP:20260603T223454
CREATED:20251113T181510Z
LAST-MODIFIED:20251113T181510Z
UID:10000947-1775464200-1775489400@www.califesciences.org
SUMMARY:From the Laboratory to Leadership | Virtual
DESCRIPTION:Elevate the pace\, performance\, and culture of your company’s greatest assets. Built from over 30 years of success with more than 7\,500 graduates from over 1\,000 life science companies\, From the Laboratory to Leadership program guides first-time managers\, and those seeking to expand their management skills\, into capable business leaders. This fully redesigned program leverages extensive industry-specific knowledge and experience to utilize the most progressive and engaging professional development methods available. \nProgram dates: April 6\, April 20\, May 4\, and May 18 \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/laboratory-to-leadership-virtual/
LOCATION:https://www.califesciences.org/event/laboratory-to-leadership-virtual/
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260402T100000
DTEND;TZID=America/Los_Angeles:20260402T130000
DTSTAMP:20260603T223454
CREATED:20260305T204138Z
LAST-MODIFIED:20260305T204138Z
UID:10001034-1775124000-1775134800@www.califesciences.org
SUMMARY:Herding Cats 3.0: Big Pharma Panel
DESCRIPTION:What does it really take to build a successful strategic partnership in life sciences? For today’s business development leaders\, identifying which opportunities will genuinely help accelerate growth can be challenging. \nIn this dynamic program\, attendees will hear from Johnson & Johnson’s External Innovation Group deal-making experts\, who will provide strategic guidance on core collaboration capabilities such as: \n\nPartnership lifecycle management\nValuation fundamentals\nNegotiation and communication strategies\n\nFollowing the main presentation\, attendees will be invited to join an exclusive panel discussion featuring Lesley Stolz\, Head of West North America\, External Scientific Innovation\, Johnson & Johnson\, alongside additional Big Pharma representatives\, who will share how established organizations evaluate partnership opportunities and what emerging companies should understand when engaging with large pharmaceutical partners. \nDesigned specifically for business development professionals\, life science innovators\, and startup founders in oncology\, immunology\, and neuroscience\, this event will deliver practical knowledge to help maximize meaningful collaborations in 2026 and beyond. \nPlease note: This is an apply-to-attend event. The application deadline is March 11th\, and approved attendees will be notified by March 16. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/herding-cats-3-0-big-pharma-panel/
LOCATION:JLABS@SSF\, 329 OYSTER POINT BLVD.\, SOUTH SF\, CA\, 94080\, United States
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/12/NorCal-Industry-Event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260401T080000
DTEND;TZID=America/Los_Angeles:20260401T090000
DTSTAMP:20260603T223454
CREATED:20260327T183718Z
LAST-MODIFIED:20260327T183718Z
UID:10001046-1775030400-1775034000@www.califesciences.org
SUMMARY:Precision in Human Biological Samples: Leveraging Regulatory Rigor and Deep Data for Advanced Disease Research
DESCRIPTION:Join BioIVT and France Tissue Bank experts to explore how high-quality biospecimens\, longitudinal data\, and regulatory rigor drive the future of biomarker discovery. Using an Alzheimer’s disease use case\, discover the critical role of pre-analytical rigor\, matched sample sets\, and demographic diversity. Learn to navigate ISO standards\, optimize sample selection for AI and clinical diagnostics\, and ensure reproducibility for your scientific projects. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/precision-in-human-biological-samples/
LOCATION:https://www.califesciences.org/event/precision-in-human-biological-samples/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260330T083000
DTEND;TZID=America/Los_Angeles:20260330T163000
DTSTAMP:20260603T223454
CREATED:20251113T181003Z
LAST-MODIFIED:20251113T181003Z
UID:10000946-1774859400-1774888200@www.califesciences.org
SUMMARY:From the Laboratory to Leadership | San Diego
DESCRIPTION:Elevate the pace\, performance\, and culture of your company’s greatest assets. Built from over 30 years of success with more than 7\,500 graduates from over 1\,000 life science companies\, From the Laboratory to Leadership program guides first-time managers\, and those seeking to expand their management skills\, into capable business leaders. This fully redesigned program leverages extensive industry-specific knowledge and experience to utilize the most progressive and engaging professional development methods available. \nProgram dates: March 30\, April 13\, April 27\, and May 11 \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/from-the-laboratory-to-leadership-san-diego/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Industry Events,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/SoCal-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260330T083000
DTEND;TZID=America/Los_Angeles:20260330T140000
DTSTAMP:20260603T223454
CREATED:20260217T165533Z
LAST-MODIFIED:20260217T165533Z
UID:10001019-1774859400-1774879200@www.califesciences.org
SUMMARY:Development of Radiopharmaceuticals: Fundamentals\, Landscape\, BD Deals\, CMC Challenges\, Theranostic Development\, and IP strategies
DESCRIPTION:This workshop offers a comprehensive deep dive into the rapidly evolving field of radiopharmaceuticals. The agenda spans the full development lifecycle\, beginning with a high-level view of the market landscape\, deal-making trends\, and future directions in oncology and beyond. Expert sessions will tackle critical technical hurdles\, including CMC challenges\, theranostic development\, and manufacturing for first-in-human trials. Attendees will also gain insights into clinical strategies\, such as dose selection and PET imaging agents\, alongside essential legal considerations regarding IP strategy. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/development-of-radiopharmaceuticals/
LOCATION:https://www.califesciences.org/event/development-of-radiopharmaceuticals/
CATEGORIES:Industry Events,Industry Supported
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260326T110000
DTEND;TZID=America/Los_Angeles:20260326T120000
DTSTAMP:20260603T223454
CREATED:20260302T185341Z
LAST-MODIFIED:20260302T185341Z
UID:10001026-1774522800-1774526400@www.califesciences.org
SUMMARY:Aligning With the FDA on a Regulatory Pathway To Avoid Decision Day Surprises
DESCRIPTION:During the past seven months\, biopharma companies have had to contend with unprecedented change within the upper echelons of the FDA. Among other challenges\, executives at small and medium companies have reported communication issues\, misaligned expectations and media leaks while attempting to get their products across the regulatory finish line. \nNotably\, many of these investigational therapies have targeted rare diseases affecting primarily children—products that FDA Commissioner Marty Makary and Center for Biologics and Research Director Vinay Prasad have vowed to expedite to the market. \nAt the same time\, the FDA has outlined its commitment to aligning with drug sponsors on the regulatory approval process\, with Makary and Prasad stating in a JAMA article published in June that they intend to provide “the regulatory navigation that [small] companies may lack internally.” \nIt’s clear that both the FDA and biopharma companies developing medicines for rare diseases want the same thing but there remains a disconnect. This panel discussion will look at how to leverage FDA frameworks\, define expectations and adopt modern technologies\, including AI and in silico models\, to increase the likelihood of success. \nREGISTER» \nHosted by:
URL:https://www.califesciences.org/event/aligning-with-the-fda-on-a-regulatory-pathway/
LOCATION:https://www.califesciences.org/event/aligning-with-the-fda-on-a-regulatory-pathway/
CATEGORIES:Industry Events,Industry Supported,Professional Development
ATTACH;FMTTYPE=image/png:https://www.califesciences.org/wp-content/uploads/2025/11/Virtual-Industry-Event-1.png
END:VEVENT
END:VCALENDAR